Biological E receives DCGI approval for administration of Corbevax in children aged 12 to 18 years

Biological E receives DCGI approval for administration of Corbevax in children aged 12 to 18 years

By, Admin 22 February 2022

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein subunit vaccine against COVID-19. The vaccine had already received approval for restricted use in emergency situations among adults. Biological E. Limited (BE) today received Emergency Use Authorisation (EUA) from the Drugs Controller General of India (DCGI) for the administration of its Corbevax vaccine in children aged 12 to 18 years. The approval for restricted use in an emergency situation by the Indian drug regulator was granted on the basis of interim results of the ongoing phase II/III clinical study. Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein subunit vaccine against COVID-19. The vaccine had already received approval for restricted use in emergency situations among adults on December 28, 2020. Highlighting the benefits of expanding the vaccine to children, Mahima Datla, Managing Director, Biological E. Limited, said,

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!